Glatiramer Acetate

Glatiramer (acetate) is a mixture of synthetic polycpeptides composed of four amino acids found in myelin basic protein (MBP): L-Alanine, L-glutamic acid, L-lysine, and L-tyrosine. It prevents MBP from binding to MHC class II molecules in the periphery and induces the production of immunomodulatory molecules considered to be anti-inflammatory. 1 It aslso increases proliferation of oligodendrocyte and neuronal precursor cells in the central nervous system of mice. Formulations containing Glatiramer (acetate) are used to treat patients with multiple sclerosis, particular the relapsing-remiting type.

Glatiramer acetate is a random basic synthetic copolymere of L-alanine, L-Lysine, L-glutamic acid and L-tyrosine in a molar ratio of 6:1.9:4.7:1. Glatiramer acetate is an immunomodulator used in treatment of multiple sclerosis.

L-alanine: C₃H₇NO₂
L-lysine: C₆H₁₄N₂O₂
L-glutamic acid: C₅H₉NO₄
L-tyrosine: C₉H₁₁NO₃

Small volumes of Glatiramer Acetate biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS6069135 is a biochemical targeting Glatiramer Acetate.